Ionis Pharmaceuticals (IONS) and Ono Pharmaceutical announced that the two companies have entered into a license agreement in which Ono obtains ...

Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under ...

ACADIA Pharmaceuticals is headquartered in San Diego, CA. The company has two products on the market. The first is its flagship drug Nuplazid which was approved in 2016 and remains the only ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

JMP Securities analyst Jason Butler reiterated a Hold rating on Athira Pharma (ATHA – Research Report) today. The company’s shares closed yesterday at $0.42. See what stocks are receiving ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to ...

TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...

Investing.com - Crinetics Pharma (NASDAQ: CRNX) reported second quarter EPS of $-0.94, $0.07 worse than the analyst estimate of $-0.87. Revenue for the quarter came in at $1M... ByInvesting.com ...

Annora Pharma’s ANDA Challenge to Orladeyo’s Patents In January 2025, Annora Pharma filed an ANDA with the FDA seeking approval to market a generic version of Orladeyo. Annora is challenging ...